Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$994M |
| 2 |
Cigna
CI
|
+$524M |
| 3 |
Microsoft
MSFT
|
+$395M |
| 4 |
Amazon
AMZN
|
+$281M |
| 5 |
CVS Health
CVS
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$918M |
| 2 |
AET
Aetna Inc
AET
|
+$761M |
| 3 |
PX
Praxair Inc
PX
|
+$581M |
| 4 |
COL
Rockwell Collins
COL
|
+$274M |
| 5 |
CA
CA, Inc.
CA
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.98% |
| 2 | Financials | 14.41% |
| 3 | Healthcare | 13.78% |
| 4 | Consumer Discretionary | 9.86% |
| 5 | Industrials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RTL
2851
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $2.87M | ﹤0.01% |
215,265
+126,516
| +143% | +$1.74M |
|
|
CBMG
2852
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $2.86M | ﹤0.01% |
162,102
-2,213
| -1% | -$37.6K |
|
2853
Cytosorbents Corp
CTSO
$22.6M
| $2.85M | ﹤0.01% |
353,176
-7,640
| -2% | -$75.9K |
|
2854
Oppenheimer Holdings
OPY
$1.21B
| $2.85M | ﹤0.01% |
111,403
-275
| -0.2% | -$7.88K |
|
2855
ACNB Corp
ACNB
$655M
| $2.85M | ﹤0.01% |
72,521
+1,273
| +2% | +$48.1K |
|
2856
Blue Bird Corp
BLBD
$2.1B
| $2.84M | ﹤0.01% |
156,130
-4,823
| -3% | -$93.9K |
|
|
IIN
2857
DELISTED
IntriCon Corporation
IIN
| $2.84M | ﹤0.01% |
107,608
+1,375
| +1% | +$52.3K |
|
|
CBPO
2858
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $2.83M | ﹤0.01% |
37,340
-866
| -2% | -$63.7K |
|
|
FTSI
2859
DELISTED
FTS International, Inc. Common Stock
FTSI
| $2.83M | ﹤0.01% |
19,898
-116
| -0.6% | -$24.5K |
|
2860
Impinj
PI
$5.32B
| $2.83M | ﹤0.01% |
194,402
-12,584
| -6% | -$247K |
|
2861
Sibanye-Stillwater
SBSW
$7.51B
| $2.83M | ﹤0.01% |
999,257
-176,141
| -15% | -$477K |
|
2862
RCI Hospitality Holdings
RICK
$210M
| $2.83M | ﹤0.01% |
126,501
-621
| -0.5% | -$15.6K |
|
2863
Clean Energy Fuels
CLNE
$377M
| $2.81M | ﹤0.01% |
1,635,848
+30,811
| +2% | +$68.2K |
|
|
BLMT
2864
DELISTED
BSB Bancorp, Inc.
BLMT
| $2.81M | ﹤0.01% |
100,201
+1,718
| +2% | +$51.2K |
|
|
LJPC
2865
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $2.81M | ﹤0.01% |
297,893
-6,333
| -2% | -$95.3K |
|
|
BPL
2866
DELISTED
Buckeye Partners, L.P.
BPL
| $2.8M | ﹤0.01% |
96,670
-20,500
| -17% | -$652K |
|
|
ALBO
2867
DELISTED
Albireo Pharma Inc
ALBO
| $2.79M | ﹤0.01% |
113,693
-26
| -0% | -$687 |
|
2868
Hurco Companies Inc
HURC
$143M
| $2.78M | ﹤0.01% |
77,758
-686
| -0.9% | -$27.4K |
|
2869
Verastem
VSTM
$638M
| $2.77M | ﹤0.01% |
68,745
-1,721
| -2% | -$105K |
|
2870
iShare MSCI Eurozone ETF
EZU
$9.91B
| $2.76M | ﹤0.01% |
78,753
-29,879
| -28% | -$1.12M |
|
|
RUBY
2871
DELISTED
Rubius Therapeutics, Inc
RUBY
| $2.75M | ﹤0.01% |
171,245
+36,674
| +27% | +$669K |
|
2872
RBB Bancorp
RBB
$458M
| $2.74M | ﹤0.01% |
155,950
+6,729
| +5% | +$144K |
|
|
BELFB
2873
Bel Fuse Inc Class B
BELFB
$4.19B
| $2.73M | ﹤0.01% |
148,492
-874
| -0.6% | -$19.7K |
|
2874
Vanguard Total World Stock ETF
VT
$81.1B
| $2.73M | ﹤0.01% |
41,755
+13,961
| +50% | +$977K |
|
2875
Culp Inc
CULP
$43.7M
| $2.72M | ﹤0.01% |
143,781
+2,067
| +1% | +$44.7K |
|
Similar funds
Northern Trust's Q4 2018 Portfolio in Review
As of Q4 2018, Northern Trust held 4,401 positions worth $357B, down 13% from $409B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 5%. Northern Trust opened 95 new positions and exited 125, leaving the 4,401-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2018 buy was Linde: 6,288,266 shares worth $981M.
- Northern Trust added most to Cigna in Q4 2018, an estimated $524M increase.
- Northern Trust's biggest Q4 2018 reduction was FlexShares iBoxx 3-Year Target Duration TIPS Index Fund, cutting an estimated $224M.
- Northern Trust fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $918M.
- Northern Trust's ten largest holdings make up 16% of its $357B portfolio in Q4 2018.
- Northern Trust opened 95 new positions and closed 125 in Q4 2018.
- Northern Trust's portfolio value fell 13% quarter-over-quarter to $357B.
Based on Northern Trust's 13F filing for Q4 2018, filed 12 Feb 2019.